Products injury firm Hissey Kientz LLP recently issued a press release that addresses reported adverse effects of Reglan (metoclopramide). The firm undertook an analysis of data in the FDA’s Adverse Event Reporting System related to the stomach disorder drug, and “identified at least 106 cases of tardive dyskinesia or other movement disorders reported among users of Reglan or its generic version, metoclopramide.”
Featured Stem Projects
Canada's online legal magazine
A directory of Canadian legal blogs, sorted by location, practice area, and more.
A site tracking the latest in Canadian Legal Publications.
Stem's annual contest celebrating the best in Canadian Legal Blogging.